Boom in weight-loss drugs to drive up US employers’ medical costs in 2024: consultant
Booming demand for newer weight-loss and diabetes drugs is expected to accelerate the rise in medical expenses for employers in the United States next year, staff health benefits consultant Mercer said on Friday.